Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_efb35e154fff5d3177ae8520d41046d5 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-117 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1132 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
filingDate |
1994-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb9299cc5b998e198d1375e85788d0b4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c34f820b5bf71df4aa03893080b793d6 |
publicationDate |
1995-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-9503407-A2 |
titleOfInvention |
Oligonucleotides with activity against human immunodeficiency virus |
abstract |
The present invention features compounds and methods for inhibiting propagation of human immunodeficiency virus (HIV). Preferred HIV target sites are identified and oligonucleotides designed to hybridize to a target site are described. The preferred use of the oligonucleotides is as an anti-HIV agent to inhibit HIV propagation in a patient infected with HIV. Other uses of the present invention include detecting the presence of HIV by using the oligonucleotides as detection probes or amplification primers, and measuring the ability of an oligonucleotide to inhibit HIV propagation to evaluate its suitability as an anti-HIV agent for a phenotype of HIV or diagnose the presence of HIV in a patient. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5932450-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5756352-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5759519-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7943375-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7807803-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-19908766-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6582920-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5739271-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8129351-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8133494-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6776986-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5739311-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7374877-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7723500-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0104361-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5711964-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7998492-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5652126-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7741027-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0104361-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6623920-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8834900-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022098268-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5851548-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011005220-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6946254-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5916777-A |
priorityDate |
1993-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |